Human FcRn expression and Type I Interferon signaling control Echovirus 11 pathogenesis in mice.
Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade.
Animal models for SARS-Cov2/Covid19 research-A commentary.
The ability of Zika virus intravenous immunoglobulin to protect from or enhance Zika virus disease.
LJI and Charles River Laboratories to collaborate on COVID-19 research
New agreement paves the way for better mouse models to study how the human immune system fights SARS-CoV-2
LJI and Synbal, Inc. partner to develop better COVID-19 models
New mouse models may shed light on the puzzling aspects of SARS-CoV-2 infection
If You Don’t Have COVID Vaccine Side Effects, Are You Still Protected?
Reactions reflect unique features of an individual’s immune system, not the strength of a response
Building true partnerships with overseas labs
As she advances global health, LJI Professor Sujan Shresta takes on three new research projects to support equity for scientists in South and Southeast Asia